Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Watch Dopesick on Disney Plus

<< Previous

Bullboard Posts

Next >>

Post by Forestviewon Jan 03, 2023 11:19am

858 Views

Post# 35200727

Watch Dopesick on Disney Plus

Hey all, happy new year. Like many of you, I took the time to binge watch some TV over the holidays. One show I recommend all of you to watch is Dopesick, based on Purdue Pharma's development of OxyContin, and how its highly addictive nature (which Purdue grossly downplayed) decimated the lives of tens of thousands of people. If anyone wonders what ATE is doing, and the potential impact it may have on the world, this series will reinforce its importance.

I hope ATE continues to make progress in 2023, there is a real, tangible market for Otena, and others.

Good luck longs.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December